179 related articles for article (PubMed ID: 37525510)
21. Medications for management of opioid use disorder.
Koehl JL; Zimmerman DE; Bridgeman PJ
Am J Health Syst Pharm; 2019 Jul; 76(15):1097-1103. PubMed ID: 31361869
[TBL] [Abstract][Full Text] [Related]
22. Availability of Long-Acting Injectable Buprenorphine at Substance Use Treatment Facilities in 2021.
Vidyasagar N; Bunting SR; Arora VM; Ari M
JAMA; 2024 Feb; 331(6):524-526. PubMed ID: 38236586
[TBL] [Abstract][Full Text] [Related]
23. Enhancing engagement between legislators and nursing to increase buprenorphine access.
Finnell DS; Schimmels J; Tierney M
Nurs Outlook; 2023; 71(4):102004. PubMed ID: 37429154
[No Abstract] [Full Text] [Related]
24. Buprenorphine Out-of-Pocket Costs and Discontinuation in Privately Insured Adults With Opioid Use Disorder.
Leech AA; McNeer E; Roberts AW; Dusetzina SB; Lai P; Morgan JR; Patrick SW
JAMA Intern Med; 2023 Sep; 183(9):1023-1026. PubMed ID: 37548972
[TBL] [Abstract][Full Text] [Related]
25. Discontinuing Methadone and Buprenorphine: A Review and Clinical Challenges.
Zweben JE; Sorensen JL; Shingle M; Blazes CK
J Addict Med; 2021 Nov-Dec 01; 15(6):454-460. PubMed ID: 33323695
[TBL] [Abstract][Full Text] [Related]
26. Rapid upscale of depot buprenorphine (CAM2038) in custodial settings during the early COVID-19 pandemic in New South Wales, Australia.
Roberts J; White B; Attalla D; Ward S; Dunlop AJ
Addiction; 2021 Feb; 116(2):426-427. PubMed ID: 32888226
[No Abstract] [Full Text] [Related]
27. Expanding Access to Medications for Opioid Use Disorder: Federal Policy Is Only a Part of the Solution.
Heidari O; Banta-Green CJ
Am J Public Health; 2024 Jul; 114(7):693-695. PubMed ID: 38838294
[No Abstract] [Full Text] [Related]
28. Use of naltrexone in treating opioid use disorder in pregnancy.
Towers CV; Katz E; Weitz B; Visconti K
Am J Obstet Gynecol; 2020 Jan; 222(1):83.e1-83.e8. PubMed ID: 31376396
[TBL] [Abstract][Full Text] [Related]
29. Within-subject evaluation of interim buprenorphine treatment during waitlist delays.
Oleskowicz TN; Ochalek TA; Peck KR; Badger GJ; Sigmon SC
Drug Alcohol Depend; 2021 Mar; 220():108532. PubMed ID: 33508690
[TBL] [Abstract][Full Text] [Related]
30. Use of Buprenorphine to Treat Opioid Use Disorder.
Bartholow LAM; Pope J
J Psychosoc Nurs Ment Health Serv; 2018 Nov; 56(11):9-12. PubMed ID: 30383881
[TBL] [Abstract][Full Text] [Related]
31. Biotechnologies and the future of opioid addiction treatments.
Wolfe D; Saucier R
Int J Drug Policy; 2021 Feb; 88():103041. PubMed ID: 33246267
[TBL] [Abstract][Full Text] [Related]
32. Innovations in efforts to expand treatment for opioid use disorder.
Sigmon SC
Prev Med; 2019 Nov; 128():105818. PubMed ID: 31445112
[TBL] [Abstract][Full Text] [Related]
33. Commentary on Hser et al. (2014): to retain or not to retain-open questions in opioid maintenance therapy.
Soyka M; Hillemacher T
Addiction; 2014 Jan; 109(1):88-9. PubMed ID: 24438113
[No Abstract] [Full Text] [Related]
34. Use and misuse of opioid replacement therapies: a Queensland study.
Smirnov A; Kemp R
Subst Use Misuse; 2012 Jan; 47(1):78-85. PubMed ID: 22216993
[TBL] [Abstract][Full Text] [Related]
35. 'I just thought that was the best thing for me to do at this point': Exploring patient experiences with depot buprenorphine and their motivations to discontinue.
Clay S; Treloar C; Degenhardt L; Grebely J; Christmass M; Gough C; Hayllar J; McDonough M; Henderson C; Crawford S; Farrell M; Marshall A
Int J Drug Policy; 2023 May; 115():104002. PubMed ID: 37003194
[TBL] [Abstract][Full Text] [Related]
36. TIME TO REVISIT UNEVEN POLICY IN THE UNITED STATES FOR MEDICATION FOR OPIOID USE DISORDER DURING COVID-19.
Pena E; Ahmed S
Addiction; 2020 Oct; 115(10):1978-1979. PubMed ID: 32447795
[No Abstract] [Full Text] [Related]
37. A Guide to Expanding the Use of Buprenorphine Beyond Standard Initiations for Opioid Use Disorder.
Miller JC; Brooks MA; Wurzel KE; Cox EJ; Wurzel JF
Drugs R D; 2023 Dec; 23(4):339-362. PubMed ID: 37938531
[TBL] [Abstract][Full Text] [Related]
38. Buprenorphine for Persons on Waiting Lists for Treatment for Opioid Dependence.
Yan K
N Engl J Med; 2017 Mar; 376(10):1000. PubMed ID: 28276662
[No Abstract] [Full Text] [Related]
39. Buprenorphine for Persons on Waiting Lists for Treatment for Opioid Dependence.
Sigmon SC; Schwartz RP; Higgins ST
N Engl J Med; 2017 Mar; 376(10):1000-1001. PubMed ID: 28273017
[No Abstract] [Full Text] [Related]
40. Pharmacological treatment of opioid use disorder in pregnancy.
Rodriguez CE; Klie KA
Semin Perinatol; 2019 Apr; 43(3):141-148. PubMed ID: 30755340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
